Skip to main content
. Author manuscript; available in PMC: 2017 Nov 7.
Published in final edited form as: J Gastroenterol Hepatol. 2017 Jun;32(6):1250–1257. doi: 10.1111/jgh.13667

Figure 2.

Figure 2

Predicted mean of trajectories of log10 viral load and fibrosis-4 (FIB4) over time by treatment groups after excluding “never immunologically active” patients (no ALT > 2*upper limit of normal or viral load > 2000 IU/mL from index date to last observation). Shaded area: 95% confidence band.